EcoDrugPlus

Cathepsin C

Ensembl ID : ENSCMIG00000013900
Gene Symbol: CTSC
4 Cross references
239 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSCMIG00000007878
Gene Symbol: CDC7
4 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSCMIG00000005779
Gene Symbol: CHEK1
4 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSCMIG00000014332
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCMIG00000011014
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSCMIG00000001150
Gene Symbol: LOC103171874
3 Cross references
270 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSCMIG00000011788
Gene Symbol: CETP
3 Cross references
151 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSCMIG00000013319
Gene Symbol: CHRM2
4 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSCMIG00000014233
Gene Symbol: CHRM3
4 Cross references
257 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSCMIG00000008603
Gene Symbol: CHRM4
4 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSCMIG00000009406
Gene Symbol: CHRM5
3 Cross references
264 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSCMIG00000008111
Gene Symbol: CHRNA3
4 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).